07.02.2023 - FREMONT, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) - Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday, .